Self‐Assembling P38 Peptide Inhibitor Nanoparticles Ameliorate the Transition from Acute to Chronic Kidney Disease by Suppressing Ferroptosis
Advanced Healthcare Materials · 2024-09 · 13 (23)
DOI: 10.1002/adhm.202400441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.05.2024. Verfasst von Wang Xin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Cen…. Hauptthemen laut MEDLINE: Ferroptosis, Nanoparticles, Renal Insufficiency, Chronic, Acute Kidney Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Key R&D Program of China, National Excellent Youth Fund Program, Key program of the Natural Science Foundation of China.
Abstract (Originalsprache)
Accumulating evidence highlights p38 as a crucial factor highly activated during the process of acute kidney injury (AKI), but the application of p38 inhibitor in AKI is quite limited due to the low efficiency and poor kidney‐targeting ability. Herein, a novel self‐assembling peptide nanoparticle with specific p38‐inhibiting activity is constructed, which linked mitogen‐activated protein kinase kinase 3b (MKK3b), the functional domain of p38, with the cell‐penetrating TAT sequence, ultimately self‐assembling into TAT‐MKK3b nanoparticles (TMNPs) through tyrosinase oxidation. Subsequent in vitro and in vivo studies demonstrated that TMNPs preferably accumulated in the renal tubular epithelial cells (RTECs) through forming protein coronas by binding to albumin, and strongly improved the reduced renal function of ischemia‐reperfusion injury (IRI)‐induced AKI and its transition to chronic kidney disease (CKD). Mechanically, TMNPs inhibited ferroptosis via its solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) axis‐inducing capacity and synergistic potent antioxidant property in AKI. The findings indicated that the multifunctional TMNPs exhibited renal targeting, ROS‐scavenging, and ferroptosis‐mitigating capabilities, which may serve as a promising therapeutic agent for the treatment of AKI and its progression to CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical Uni…
- Institute of Combined Injury, State Key Laboratory of Trauma, Burns and Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, Chongqing, 400038…
- State Key Laboratory of Protein and Plant Gene Research, College of Life Science, Peking University, Beijing, 100871, China.
ORCID-Profile: Yinghui Huang
Förderung
- National Key R&D Program of China
- National Excellent Youth Fund Program
- Key program of the Natural Science Foundation of China
- Natural Science Foundation of China
- Frontier specific projects of Xinqiao Hospital
- Clinical Medicine Research of Army Medical University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Xin, W., Gong, S., Chen, Y., Yao, M., Qin, S., Chen, J., Zhang, A., Yu, W., Zhou, S., Zhang, B., Gu, J., Zhao, J., & Huang, Y. (2024). Self‐Assembling P38 Peptide Inhibitor Nanoparticles Ameliorate the Transition from Acute to Chronic Kidney Disease by Suppressing Ferroptosis. Advanced Healthcare Materials, 13(23). https://doi.org/10.1002/adhm.202400441
Vancouver
Xin W, Gong S, Chen Y, Yao M, Qin S, Chen J, et al. Self‐Assembling P38 Peptide Inhibitor Nanoparticles Ameliorate the Transition from Acute to Chronic Kidney Disease by Suppressing Ferroptosis. Advanced Healthcare Materials. 2024;13(23). doi:10.1002/adhm.202400441
BibTeX
@article{Xin2024,
author = {Xin, Wang and Gong, Shuiqin and Chen, Yin and Yao, Mengying and Qin, Shaozong and Chen, Jing and Zhang, Aihong and Yu, Wenrui and Zhou, Siyan and Zhang, Bo and Gu, Jun and Zhao, Jinghong and Huang, Yinghui},
title = {Self‐Assembling P38 Peptide Inhibitor Nanoparticles Ameliorate the Transition from Acute to Chronic Kidney Disease by Suppressing Ferroptosis},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {23},
doi = {10.1002/adhm.202400441}
}
EUVIMED